IL284835A
(en )
2021-08-31
Pharmaceutical combination containing TNO155 and ribociclib
GB201807942D0
(en )
2018-06-27
Pharmaceutical formulation
EP3706741A4
(en )
2022-03-30
PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3434285A4
(en )
2019-10-30
PHARMACEUTICAL COMPOSITION AND USES THEREOF
IL273339A
(en )
2020-05-31
Griseofulbin compound and its medical use
GB201709141D0
(en )
2017-07-26
Pharmaceutical formulation
ZA202102871B
(en )
2023-04-26
Pharmaceutical formulation
SG11202010124SA
(en )
2020-11-27
Stable pharmaceutical formulation
IL276323A
(en )
2020-09-30
4-Methyldihydropyrimidinone compounds and their pharmaceutical use
IL278927A
(en )
2021-01-31
pharmaceutical preparation
HK1250147A1
(zh )
2018-11-30
一種凍干藥物製劑及其用途
IL279877A
(en )
2021-03-01
Ibusidanib forms and pharmaceutical preparations
FI3601277T3
(fi )
2024-01-09
Farmaseuttinen formulaatio
EP3497080A4
(en )
2020-07-29
PHARMACEUTICAL FORMULATIONS AND THEIR USE
EP3851108C0
(en )
2023-08-09
BORATE-BASED MEDICINE AND ASSOCIATED USE
EP3647325A4
(en )
2021-03-17
PHARMACEUTICAL COMPOSITION OF PCSK-9 ANTIBODIES AND USES THEREOF
EP4069233A4
(en )
2024-03-13
PHARMACEUTICAL COMBINATION AND USE THEREOF
ZA202100166B
(en )
2021-09-29
Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
IL282142A
(en )
2021-05-31
The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine
ZA202000959B
(en )
2021-08-25
Adamantylmethylamine derivative and use thereof as pharmaceutical
GB201905509D0
(en )
2019-06-05
Pharmaceutical compositions and associated lits and uses
EP3718543A4
(en )
2021-07-21
PHARMACEUTICAL COMPOSITION AND ITS USE
HK1254527A1
(zh )
2019-07-19
藥物調配物和其用途
EP3763373A4
(en )
2021-05-12
PHARMACEUTICAL FORMULATION AND ITS USES
IL292646A
(en )
2022-07-01
Pharmaceutical combination and its use